A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy

By Shin Sang  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 672-680

Springer Publishing Company

Access to resources Recommend Favorite

A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer

By Murren John   Modiano Manuel   Kummar Shivaani   Clairmont Caroline   Egorin Merrill   Chu Edward   Sznol Mario  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 123-135

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies

By Argiris Athanassios  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1575-1584

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Clinical and Pharmacokinetic Study of Fenretinide Combined with Paclitaxel and Cisplatin for Refractory Solid Tumors

By Otterson G.   Lavelle J.   Villalona-Calero M.   Shah M.   Wei X.   Chan K.   Fischer B.   Grever M.  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 555-562

Springer Publishing Company

Access to resources Recommend Favorite

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients

By Flaig Thomas   Gustafson Daniel   Su Lih-Jen   Zirrolli Joseph   Crighton Frances   Harrison Gail   Pierson A.   Agarwal Rajesh   Glodé L.  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 139-146

Springer Publishing Company

Access to resources Recommend Favorite